China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro® streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Junshi Biosciences Announces Toripalimab s NDA Accepted by the Singapore Health Sciences Authority wahanariau.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wahanariau.com Daily Mail and Mail on Sunday newspapers.
SHENZHEN, CHINA, Feb. 03, 2024 (GLOBE NEWSWIRE) China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 2 February.
China Medical System (00867） Obtained Exclusive License Of A First-Line Phosphate-Lowering Drug Velphoro® menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects growth to accelerate significantly in 2025 as diagnosis methods change, a company spokesperson told Reuters. More convenient Alzheimer's blood tests expected to be ready then could help Eisai reach a bigger share of China’s estimated 17 million people with early-stage disease, the spokesperson said. “China is one of the fastest-aging countries in the world and is one of the most important countries in the area of Alzheimer’s disease for Eisai,” a company spokesperson said.